Advances in understanding cell interactions in tissue resorption. Relevance to the pathogenesis of periodontal diseases and a new hypothesis.
Much of the connective tissue degradation that takes place in periodontal diseases is mediated by proteolytic enzymes. Previous studies have focused on the action of proteinases released by invading polymorphonuclear neutrophils and macrophages, and bacterial enzymes. In view of recent work establishing that resident connective tissue cells can be induced by cytokines to bring about the destruction of their own matrix, we propose a new hypothesis. In this we envisage that a critical step is the interaction of bacterial antigens with inflammatory cells, resulting in the production of a cytokine, interleukin-1. Our interpretation of in vitro evidence is that the loss of connective tissue attachment and bone matrix resorption in periodontal diseases is mediated by metalloproteinases such as collagenase and stromelysin released by cells of the periodontium. Such proteolytic destruction can be induced by interleukin-1, whose production may not be dependent on a specific microbial flora but may be triggered by a number of organisms. It is now clear that interleukin-1 has multiple actions on both immune and non-immune cells; these include the induction of lymphocyte differentiation and proliferation and the stimulation of bone and cartilage resorption, and prostaglandin and metalloproteinase synthesis by connective tissues. It seems likely that further knowledge about the production and function of this cytokine will have an increasing impact in many diseases that involve resorption, particularly since interleukin-1-like molecules can be produced by cell types other than monocytes/macrophages, including keratinocytes and fibroblasts.
D000539:Alveolar Process / Q000201:enzymology / Q000473:pathology; D000942:Antigens, Bacterial / Q000378:metabolism; D001688:Biological Products / Q000378:metabolism; D001862:Bone Resorption / Q000201:enzymology / Q000473:pathology; D003238:Connective Tissue / Q000201:enzymology / Q000473:pathology; D016207:Cytokines; D010450:Endopeptidases / Q000378:metabolism; D005881:Gingiva / Q000201:enzymology; D006801:Humans; D007375:Interleukin-1 / Q000378:metabolism; D008214:Lymphocytes / Q000378:metabolism*; D008222:Lymphokines / Q000378:metabolism; D008666:Metalloendopeptidases; D009000:Monocytes / Q000378:metabolism; D010510:Periodontal Diseases / Q000201:enzymology / Q000209:etiology* / Q000378:metabolism; D010519:Periodontium / Q000378:metabolism / Q000473:pathology*
D000942:Antigens, Bacterial; D001688:Biological Products; D016207:Cytokines; D007375:Interleukin-1; D008222:Lymphokines; D010450:Endopeptidases; D008666:Metalloendopeptidases